94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Giovanni Pallio1
Alessandra Bitto1*
Gabriele Pizzino1
Federica Galfo1
Natasha Irrera1
Francesco Squadrito1
Giovanni Squadrito2
Socrate Pallio1Giuseppe P. Anastasi3Giuseppina Cutroneo2
Antonio Macrì2
Domenica Altavilla3- 1Section of Pharmacology, Department of Clinical and Experimental Medicine, Medical School, University of Messina, Messina, Italy
- 2Department of Human Pathology, University of Messina, Messina, Italy
- 3Department of Biomedical Sciences and Morphological and Functional Images, University of Messina, Messina, Italy
A Corrigendum on
Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis
by Pallio G, Bitto A, Pizzino G, Galfo F, Irrera N, Squadrito F, Squadrito G, Pallio S, Anastasi GP, Cutroneo G, Macrì A and Altavilla D (2016). Front. Pharmacol. 7:273. doi: 10.3389/fphar.2016.00273
In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.
“Author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: colitis, A2A agonist, PDRN, inflammation, apoptosis
Citation: Pallio G, Bitto A, Pizzino G, Galfo F, Irrera N, Squadrito F, Squadrito G, Pallio S, Anastasi GP, Cutroneo G, Macrì A and Altavilla D (2022) Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis. Front. Pharmacol. 13:1073445. doi: 10.3389/fphar.2022.1073445
Received: 18 October 2022; Accepted: 19 October 2022;
Published: 10 November 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, Lausanne, SwitzerlandCopyright © 2022 Pallio, Bitto, Pizzino, Galfo, Irrera, Squadrito, Squadrito, Pallio, Anastasi, Cutroneo, Macrì and Altavilla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alessandra Bitto, YWJpdHRvQHVuaW1lLml0